Unlike NAD+, Niagen (NR) easily enters cells, restoring NAD+ from inside the cell
Research shows that using tirzepatide and bimagrumab together might help treat obesity by reducing fat while preserving muscle
In late 2023, the FDA added more than a dozen peptides including both BPC-157 and thymosin alpha 1 to its list of substances that should not be compounded because the agency has identified potential significant safety risks. For BPC-157, the agency warned that the peptide could trigger an immune response
Effective side effect management involves proactive measures such as maintaining adequate hydration, implementing dietary modifications, and engaging in regular physical activity
Reduces oxidative stress, may improve psoriasis, reduces cell damage in alcoholic and nonalcoholic fatty liver disease
Cost is another factor to consider